Cancer Supportive Care Clinical Trial

RECITE Study of Romiplostim for the Treatment of Chemotherapy Induced Thrombocytopenia

Objective

Clinical Trial Details

IRB Protocol Number

NCT03362177

Principal Investigator(s)

Dr. Humdum Durrani

Clinical Trial Categories

• Cancer

Sponsor(s)

Amgen

Contact

St. Bernards Clinical Trial Research at 870.336.5732

How to Participate

Contact Me